New drugs 06, part II.
Hussar
Daniel A
DA
Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, PA, USA.
D000700:Analgesics / Q000627:therapeutic use; D044482:Benzeneacetamides / Q000627:therapeutic use; D001565:Benzoates / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D000077588:Deferasirox; D004164:Diphosphonates / Q000627:therapeutic use; D004281:Docosahexaenoic Acids / Q000627:therapeutic use; D017277:Drug Approval; D004338:Drug Combinations; D004347:Drug Interactions; D016903:Drug Monitoring / Q000451:nursing; D004358:Drug Therapy / Q000451:nursing / Q000592:standards*; D064420:Drug-Related Side Effects and Adverse Reactions; D015118:Eicosapentaenoic Acid / Q000627:therapeutic use; D006801:Humans; D000077557:Ibandronic Acid; D016285:Iloprost / Q000627:therapeutic use; D007192:Indenes / Q000627:therapeutic use; D008911:Minocycline / Q000031:analogs & derivatives / Q000627:therapeutic use; D010353:Patient Education as Topic; D010648:Phenylacetates / Q000627:therapeutic use; D000069583:Pregabalin; D000078304:Tigecycline; D014230:Triazoles / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives / Q000627:therapeutic use
D000700:Analgesics; D044482:Benzeneacetamides; D001565:Benzoates; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D004338:Drug Combinations; D007192:Indenes; D010648:Phenylacetates; D014230:Triazoles; D014665:Vasodilator Agents; C414203:nepafenac; D004281:Docosahexaenoic Acids; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid; D000078304:Tigecycline; C495910:ramelteon; D015118:Eicosapentaenoic Acid; C405603:Omacor; D008911:Minocycline; D016285:Iloprost; D000077557:Ibandronic Acid; D000077588:Deferasirox